Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,254 across all filing types
Latest filing 2013-09-10 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
对外投资的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by 三诺生物传感股份有限公司 regarding an external investment in 北京糖护科技有限公司. It details the investment amount, parties involved, board approval, and the purpose and risks of the investment. The document is about a specific financing activity (investment in another company) and does not contain financial statements or quarterly/yearly results. It is not a report but an announcement of a capital investment transaction. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is about 3000 characters, which is consistent with an announcement rather than a full report.
2013-09-10 Chinese
补充更正公告
Regulatory Filings Classification · 95% confidence The document is a correction announcement related to previously disclosed information about the company's stock option and restricted stock incentive plan, including lists of incentive recipients and performance assessment criteria. It does not contain financial statements or detailed financial performance data. It is a regulatory announcement correcting prior disclosures, not a full report or financial statement. The document is about disclosure corrections and does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement correcting prior information disclosures.
2013-09-03 Chinese
独立董事关于《三诺生物传感股份有限公司股票期权与限制性股票激励计划（草案）》的独立意见
Governance Information Classification · 95% confidence The document is an independent director's opinion on a draft stock option and restricted stock incentive plan for the company. It references relevant laws and regulations regarding stock incentive plans and confirms the legality and appropriateness of the plan. The document is a formal opinion letter rather than a full report or announcement of financial results. It does not contain financial statements or earnings data, nor is it a regulatory announcement or a proxy solicitation. It is a governance-related document focused on the company's internal incentive plan and compliance with governance rules. Therefore, it fits best under Governance Information (CGR). The document length is short and it is not an announcement of a report publication, so it is not RPA or RNS.
2013-09-02 Chinese
监事会关于公司股票期权与限制性股票激励计划激励对象人员名单的核查意见
Regulatory Filings Classification · 95% confidence The document is a supervisory board's verification opinion on the list of incentive recipients under the company's stock option and restricted stock incentive plan. It references relevant laws and regulations, confirms the legitimacy and appropriateness of the incentive recipients, and includes signatures of the supervisors. The content focuses on compliance and verification related to a stock incentive plan rather than financial results, management changes, or shareholder votes. It is not an announcement of a report, nor a full financial report or earnings release. The document is a regulatory compliance statement related to stock incentive plans, which fits best under Regulatory Filings (RNS) as it does not match other more specific categories like Capital/Financing Update or Director's Dealing.
2013-09-02 Chinese
股票期权与限制性股票激励计划（草案）
Regulatory Filings Classification · 95% confidence The document is a detailed draft of a stock incentive plan (股权激励计划（草案）) for 三诺生物传感股份有限公司. It includes comprehensive information about stock options, restricted stock plans, allocation, conditions, lock-up periods, performance targets, and legal compliance references. The document is lengthy (15,000 characters) and contains substantive content about the company's equity incentive program, including detailed terms and conditions, performance criteria, and governance procedures. It is not a brief announcement or a simple notification but a full plan draft. This type of document is typically classified as a Regulatory Filing (RNS) because it is a regulatory disclosure related to equity incentive plans, which do not fall under other specific categories like capital/financing updates or management changes. It is not an Annual Report, Earnings Release, or Management Report. It is not a proxy solicitation or voting results announcement. It is a regulatory disclosure about a stock incentive plan draft, which fits best under Regulatory Filings (RNS).
2013-09-02 Chinese
第一届董事会第二十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of the company 三诺生物传感股份有限公司. It details decisions on stock option and restricted stock incentive plans, appointment of a deputy general manager and chief scientist, and authorization requests for the shareholders' meeting. The document includes voting results and procedural compliance statements. It does not contain financial statements or detailed financial performance data, nor is it a transcript or presentation. It is a board meeting resolution announcement, which fits the category of Board/Management Information (MANG). The document length is 2838 characters, which is relatively short and consistent with a meeting resolution announcement rather than a full report. Therefore, the appropriate classification is MANG with high confidence.
2013-09-02 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.